Clinical trial
The HistoSonics Investigational System for Treatment of Primary Solid Renal…
NCT05432232 · HistoSonics, Inc., Industry · Completed
Key facts
| NCT number | NCT05432232 |
|---|---|
| Title | The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy |
| Official title | The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy |
| Acronym | CAIN |
| Lead sponsor | HistoSonics, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Renal Cancer, Tumor, Solid, Kidney Cancer, Benign, Kidney Neoplasms |
| Intervention type | Device |
| Interventions | HistoSonics Investigational System |
| Enrollment | 20 |
| Start date | Mar 23, 2023 |
| Primary completion | Dec 28, 2024 |
| Completion | Jun 6, 2025 |
| First posted | Jun 27, 2022 |
| Last update posted | Dec 2, 2025 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: